We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Actin-Binding Surface on Vinculin Mediates Mechanical Aspects of Cell Movement

By LabMedica International staff writers
Posted on 07 May 2014
A team of cell biologists has obtained data that shows how two proteins, vinculin and actin, function in concert to regulate cell morphology, motility, and mechanotransduction (the conversion of mechanical signals into electrical or chemical signals) and play a critical role in metastasis.

Vinculin is a cytoskeletal scaffold protein essential for embryogenesis and cardiovascular function. More...
It localizes to focal adhesions and adherens junctions, where it connects cell surface receptors to the actin cytoskeleton. While vinculin interacts with many adhesion proteins, its interaction with filamentous actin regulates cell morphology, motility, and mechanotransduction.

Investigators at the University of North Carolina (Chapel Hill, USA) used negative-stain electron microscopy, discrete molecular dynamics techniques, and mutagenesis to develop a new model to explain the interaction between vinculin and actin. A major breakthrough in this effort was the development of mutated versions of vinculin that disrupted the actin/vinculin interaction in specific and traceable fashion.

Results published in the April 2014 online edition of the journal Structure revealed that actin-binding deficient vinculin variants expressed in vinculin knockout fibroblasts failed to correct cell-spreading defects and reduced cellular response to external force. These findings highlighted the importance of this actin-binding surface and provided the molecular basis for elucidating additional roles of this interaction, including actin-induced conformational changes that promoted actin bundling.

“Our data suggest that there is a face on the vinculin tail that has been ignored by the previous model, and that it is very important,” said first author Peter Thompson, a graduate researcher at the University of North Carolina. “In your cardiovascular system – your heart and arteries – the cells that form these organs need to stick together tightly. They do these in part by forming cell-to-cell adherens junctions. Vinculin creates a critical physical link between the actin cytoskeleton and these junctions. If you disrupt that, the hypothesis is that cells no longer respond appropriately to force and the organ suffers.”

“Our data supported a unique surface that was important for actin binding,” said senior author Dr. Sharon Campbell, professor of biochemistry and biophysics at the University of North Carolina. “Identification of this actin binding surface on vinculin has enabled us to dissect how this critical interaction controls how cells respond to force and move. This in turn, will help us better understand how dysregulation leads to disease.”

Related Links:
University of North Carolina



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.